Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dermoscopy | 6 | 2022 | 73 | 2.410 |
Why?
|
Microscopy, Confocal | 8 | 2022 | 1965 | 1.750 |
Why?
|
Keratosis, Actinic | 2 | 2022 | 71 | 1.420 |
Why?
|
Skin Neoplasms | 7 | 2022 | 5837 | 1.100 |
Why?
|
Dermatology | 4 | 2018 | 905 | 0.890 |
Why?
|
Hutchinson's Melanotic Freckle | 1 | 2022 | 26 | 0.830 |
Why?
|
Psoriasis | 2 | 2021 | 919 | 0.820 |
Why?
|
Fasciitis | 1 | 2023 | 66 | 0.810 |
Why?
|
Eosinophilia | 2 | 2023 | 555 | 0.770 |
Why?
|
Facial Neoplasms | 1 | 2022 | 126 | 0.760 |
Why?
|
Lentigo | 1 | 2020 | 37 | 0.700 |
Why?
|
Keratosis, Seborrheic | 1 | 2020 | 29 | 0.680 |
Why?
|
Lichen Planus | 1 | 2020 | 70 | 0.660 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2020 | 3359 | 0.640 |
Why?
|
Dermatomyositis | 4 | 2023 | 260 | 0.630 |
Why?
|
Melanoma | 4 | 2022 | 5696 | 0.620 |
Why?
|
Bowen's Disease | 1 | 2018 | 13 | 0.600 |
Why?
|
Eczema | 1 | 2020 | 246 | 0.580 |
Why?
|
Melanocytes | 1 | 2021 | 504 | 0.570 |
Why?
|
Pruritus | 1 | 2020 | 377 | 0.540 |
Why?
|
Connective Tissue Diseases | 3 | 2022 | 284 | 0.460 |
Why?
|
Pathology | 1 | 2017 | 270 | 0.450 |
Why?
|
Pathology, Clinical | 1 | 2018 | 374 | 0.450 |
Why?
|
Quality Control | 1 | 2016 | 835 | 0.430 |
Why?
|
Access to Information | 1 | 2016 | 317 | 0.430 |
Why?
|
Lupus Erythematosus, Discoid | 2 | 2023 | 61 | 0.410 |
Why?
|
Cultural Diversity | 1 | 2016 | 370 | 0.400 |
Why?
|
Carcinoma in Situ | 1 | 2018 | 777 | 0.400 |
Why?
|
Prejudice | 1 | 2016 | 567 | 0.390 |
Why?
|
Depression | 2 | 2021 | 8224 | 0.360 |
Why?
|
Lupus Erythematosus, Systemic | 4 | 2023 | 2152 | 0.340 |
Why?
|
Skin | 2 | 2020 | 4479 | 0.330 |
Why?
|
Skin Diseases | 1 | 2018 | 1082 | 0.320 |
Why?
|
Publishing | 1 | 2016 | 835 | 0.320 |
Why?
|
Antidepressive Agents | 1 | 2020 | 2902 | 0.300 |
Why?
|
Scleroderma, Systemic | 2 | 2022 | 345 | 0.290 |
Why?
|
Periodicals as Topic | 1 | 2016 | 1462 | 0.240 |
Why?
|
Lichen Sclerosus et Atrophicus | 1 | 2023 | 26 | 0.210 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3272 | 0.210 |
Why?
|
Raynaud Disease | 1 | 2023 | 81 | 0.200 |
Why?
|
Skin Ulcer | 1 | 2023 | 130 | 0.190 |
Why?
|
Diagnosis, Differential | 3 | 2022 | 12966 | 0.190 |
Why?
|
Scleroderma, Localized | 1 | 2022 | 84 | 0.180 |
Why?
|
Sjogren's Syndrome | 1 | 2022 | 240 | 0.170 |
Why?
|
Botulinum Toxins, Type A | 1 | 2023 | 239 | 0.160 |
Why?
|
Anti-Asthmatic Agents | 1 | 2023 | 572 | 0.150 |
Why?
|
Humans | 28 | 2023 | 765823 | 0.140 |
Why?
|
Sunlight | 1 | 2018 | 335 | 0.130 |
Why?
|
Codes of Ethics | 1 | 2016 | 61 | 0.130 |
Why?
|
Carcinoma, Basal Cell | 1 | 2021 | 565 | 0.130 |
Why?
|
Skin Pigmentation | 1 | 2018 | 277 | 0.130 |
Why?
|
Pyroglyphidae | 1 | 2015 | 94 | 0.120 |
Why?
|
Registries | 2 | 2021 | 8320 | 0.120 |
Why?
|
Retrospective Studies | 6 | 2023 | 81505 | 0.110 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59506 | 0.110 |
Why?
|
Pathology, Molecular | 1 | 2016 | 329 | 0.110 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15881 | 0.100 |
Why?
|
Biological Products | 1 | 2022 | 942 | 0.100 |
Why?
|
Preoperative Care | 1 | 2020 | 2244 | 0.090 |
Why?
|
User-Computer Interface | 1 | 2017 | 1404 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1139 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1883 | 0.080 |
Why?
|
Self Report | 1 | 2020 | 3768 | 0.080 |
Why?
|
Aged | 4 | 2020 | 171178 | 0.070 |
Why?
|
Prospective Studies | 2 | 2021 | 54798 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2015 | 2324 | 0.060 |
Why?
|
Chronic Disease | 1 | 2020 | 9355 | 0.060 |
Why?
|
Female | 7 | 2023 | 396050 | 0.060 |
Why?
|
Male | 6 | 2020 | 363740 | 0.060 |
Why?
|
Middle Aged | 4 | 2020 | 223016 | 0.060 |
Why?
|
Diet | 1 | 2021 | 8085 | 0.050 |
Why?
|
Age Factors | 1 | 2020 | 18380 | 0.050 |
Why?
|
Pneumonia | 1 | 2015 | 2156 | 0.050 |
Why?
|
Curriculum | 1 | 2016 | 3780 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 22227 | 0.050 |
Why?
|
Genomics | 1 | 2016 | 5926 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14062 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2023 | 666 | 0.040 |
Why?
|
Necrosis | 1 | 2023 | 1613 | 0.040 |
Why?
|
Vitamin A | 1 | 2021 | 610 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2023 | 65223 | 0.030 |
Why?
|
Patients | 1 | 2023 | 909 | 0.030 |
Why?
|
Asthma | 1 | 2015 | 6268 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 36542 | 0.030 |
Why?
|
Adult | 2 | 2020 | 223055 | 0.030 |
Why?
|
Income | 1 | 2022 | 1873 | 0.030 |
Why?
|
Nutritional Status | 1 | 2021 | 1620 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2015 | 755 | 0.030 |
Why?
|
United States | 2 | 2021 | 72896 | 0.030 |
Why?
|
Insurance, Health | 1 | 2022 | 2521 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2386 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2015 | 1480 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3802 | 0.020 |
Why?
|
Vitamin D | 1 | 2021 | 3272 | 0.020 |
Why?
|
Hypersensitivity | 1 | 2015 | 1168 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 74853 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2015 | 5879 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2015 | 4526 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21501 | 0.010 |
Why?
|
Risk Assessment | 1 | 2023 | 24278 | 0.010 |
Why?
|
Cytokines | 1 | 2015 | 7425 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22323 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18289 | 0.010 |
Why?
|
Child | 1 | 2023 | 80509 | 0.010 |
Why?
|
Adolescent | 1 | 2023 | 88794 | 0.010 |
Why?
|
Mice | 1 | 2015 | 81788 | 0.000 |
Why?
|
Animals | 1 | 2015 | 168730 | 0.000 |
Why?
|
Concepts
(107)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_